Skip to main content
U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Biomaterials Group

The Biomaterials Group develops measurement technologies and measurement assurance strategies to quantify cells, biomaterials, and cell-material interactions.

The Biomaterials Group portfolio includes mammalian cell measurements, microbial cell measurements, biomaterials and cell-material interactions, and advanced imaging and spectroscopy.  These efforts bolster the development and translation of regenerative medicine and advanced protein-, cell-, and microbe-based therapeutics in support of the bioeconomy.

Projects and programs

Image panel of various Biomaterials Group research activites.
Credit: Biomaterials Group

News and Updates

Biomaterials Group Publications

Mechanism of Action, Potency and Efficacy: Considerations for Cell and Gene Therapies

Author(s)
Carl Simon Jr., Anne L. Plant, Catherine Zander, Erich Bozenhardt, Christina Celluzzi, David Dobnik, Melanie Grant, John Hughes, Uma Lakshmipathy, Kok-Seong Lim, Laura Montgomery, Hesham Nawar, Thiana Nebel, Linda Peltier, James Sherley, Rouzbeh Taghizadeh, Eddie Tan, Sandrine Vessillier
One of the most challenging aspects of cell and gene therapy products (CGTPs) is defining mechanism of action (MOA), potency and efficacy of the product. This